These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28973455)
1. Structural insights of lincosamides targeting the ribosome of Staphylococcus aureus. Matzov D; Eyal Z; Benhamou RI; Shalev-Benami M; Halfon Y; Krupkin M; Zimmerman E; Rozenberg H; Bashan A; Fridman M; Yonath A Nucleic Acids Res; 2017 Sep; 45(17):10284-10292. PubMed ID: 28973455 [TBL] [Abstract][Full Text] [Related]
2. Lincosamides: Chemical structure, biosynthesis, mechanism of action, resistance, and applications. Spížek J; Řezanka T Biochem Pharmacol; 2017 Jun; 133():20-28. PubMed ID: 27940264 [TBL] [Abstract][Full Text] [Related]
3. Lincosamide Antibiotics: Structure, Activity, and Biosynthesis. Mori T; Abe I Chembiochem; 2024 Mar; 25(6):e202300840. PubMed ID: 38165257 [TBL] [Abstract][Full Text] [Related]
4. Lincomycin and clindamycin conformations. A fragment shared by macrolides, ketolides and lincosamides determined from TRNOE ribosome-bound conformations. Verdier L; Bertho G; Gharbi-Benarous J; Girault JP Bioorg Med Chem; 2000 Jun; 8(6):1225-43. PubMed ID: 10896103 [TBL] [Abstract][Full Text] [Related]
5. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli. Heman-Ackah SM J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659 [TBL] [Abstract][Full Text] [Related]
6. Lincosamides: chemical structure, biosynthesis, mechanism of action, resistance, and applications. Spízek J; Novotná J; Rezanka T Adv Appl Microbiol; 2004; 56():121-54. PubMed ID: 15566978 [No Abstract] [Full Text] [Related]
7. Novel mechanisms of resistance to lincosamides in Staphylococcus and Arthrobacter spp. Quiros LM; Fidalgo S; Mendez FJ; Hardisson C; Salas JA Antimicrob Agents Chemother; 1988 Apr; 32(4):420-5. PubMed ID: 3377455 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis. Juda M; Chudzik-Rzad B; Malm A Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):155-60. PubMed ID: 27008373 [TBL] [Abstract][Full Text] [Related]
9. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus. Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721 [No Abstract] [Full Text] [Related]
10. Studies on lincosamide antibiotic resistance in methicillin-susceptible and -resistant staphylococci. Stefani S; Mezzatesta M; Gismondo MR; Romeo A; Nicoletti G Chemioterapia; 1986 Oct; 5(5):297-301. PubMed ID: 3641664 [TBL] [Abstract][Full Text] [Related]
11. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Bozdogan B; Berrezouga L; Kuo MS; Yurek DA; Farley KA; Stockman BJ; Leclercq R Antimicrob Agents Chemother; 1999 Apr; 43(4):925-9. PubMed ID: 10103201 [TBL] [Abstract][Full Text] [Related]
12. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods]. Aydeniz Ozansoy F; Cevahir N; Kaleli İ Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726 [TBL] [Abstract][Full Text] [Related]
14. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus]. Wiedemann B Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163 [No Abstract] [Full Text] [Related]
15. D test: a simple test with big implication for Staphylococcus aureus macrolide-lincosamide-streptograminB resistance pattern. Shrestha B; Rana SS Nepal Med Coll J; 2014 Sep; 16(1):88-94. PubMed ID: 25799821 [TBL] [Abstract][Full Text] [Related]
16. Correlation of agar dilution and VITEK2 system for detection of resistance to macrolides, lincosamides and pristinamycin among Staphylococcus aureus and Staphylococcus epidermidis: association with genotypes. Bémer P; Juvin ME; Corvec S; Ros A; Drugeon H Clin Microbiol Infect; 2005 Aug; 11(8):656-61. PubMed ID: 16008619 [TBL] [Abstract][Full Text] [Related]
17. Structure and mechanism of the lincosamide antibiotic adenylyltransferase LinB. Morar M; Bhullar K; Hughes DW; Junop M; Wright GD Structure; 2009 Dec; 17(12):1649-1659. PubMed ID: 20004168 [TBL] [Abstract][Full Text] [Related]
18. Lincomycin, clindamycin and their applications. Spízek J; Rezanka T Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701 [TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin]. Jakubicz P; Dzierzanowska D Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703 [No Abstract] [Full Text] [Related]
20. An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance. Wu KJY; Tresco BIC; Ramkissoon A; Aleksandrova EV; Syroegin EA; See DNY; Liow P; Dittemore GA; Yu M; Testolin G; Mitcheltree MJ; Liu RY; Svetlov MS; Polikanov YS; Myers AG Science; 2024 Feb; 383(6684):721-726. PubMed ID: 38359125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]